Skip to content
Taxonomy
CMTA Adds Science Writer Kenneth Raymond to Team
On April 17, 2023, the Charcot-Marie-Tooth Association welcomed Kenneth Raymond Read More
CMTA Partnering is Open for Business
The CMTA is a global leader in the acceleration of Read More
CMTA Funds Preclinical Work on Modulating Unfolded Protein Response in CMT1B Mice
The Charcot-Marie-Tooth (CMT) Association announced a $33,000 grant on April Read More
Gene Therapy Advances for CMT4J, CMT4A and GAN
Steven Gray, PhD, an Associate Professor at the University of Read More
Progress in CMT2D Research
Timothy J. Hines, PhD, Postdoctoral Associate at The Jackson Laboratory Read More
A New Treatment for CMT1A
DTx Pharma is directly targeting the genetic cause for CMT1A Read More
CMTA Adds Drug Development Expert Martine Garnier to STAR Advisory Board
The Charcot-Marie-Tooth Association added to its already deep bench of Read More
Applied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency
NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) — Applied Therapeutics, Read More
Shift Pharmaceuticals, CMTA Partner on ASO Treatment for CMT1A
Shift Pharmaceuticals, CMTA Partner on ASO Treatment for CMT1A GLENOLDEN, Read More
Diana Bharucha-Goebel, MD Joins the CMTA-STAR Advisory Board
In a suite of exciting appointments, the Charcot-Marie-Tooth Association (CMTA) Read More
